顶生系统/人胰岛素R/CD220(28-944)蛋白,His标签(SPR验证)/100ug/INR

价格
¥39600.00
货号:INR
浏览量:127
品牌:ACROBiosystems
服务
全国联保
正品保证
正规发票
签订合同
商品描述
  • Synonym
    INSR,Insulin receptor,IR,CD220
  • Source
    Human Insulin R (28-944), His Tag (SPR verified) (INR-H52Ha) is expressed from human 293 cells (HEK293). It contains AA His 28 - Lys 944 (Accession # P06213-2).
    Predicted N-terminus: His 28
    Request for sequence
  • Molecular Characterization
    Online(His 28 - Lys 944) P06213-2

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 106.5 kDa. The protein migrates as 115-125 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin
    Less than 1.0 EU per μg by the LAL method.
  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
SDS-PAGE
Human Insulin R (28-944), His Tag (SPR verified) (Cat. No. INR-H52Ha) SDS-PAGE gel

Human Insulin R (28-944), His Tag (SPR verified) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.

Bioactivity-ELISA
Human Insulin R (28-944), His Tag (SPR verified)Human Insulin R (28-944), His Tag (SPR verified) (Cat. No. INR-H52Ha) ELISA bioactivity

Immobilized Human Insulin R (28-944), His Tag (Cat. No. INR-H52Ha) at 5 μg/mL (100 μL/well)can bind Human IGF-II, Fc Tag (Cat. No. IG2-H4260) with a linear range of 0.078-1.25 μg/mL (QC tested).

Protocol
Human Insulin R (28-944), His Tag (SPR verified)Human Insulin R (28-944), His Tag (SPR verified) (Cat. No. INR-H52Ha) ELISA bioactivity

Immobilized Human Insulin R (28-944), His Tag (Cat. No. INR-H52Ha) at 5 μg/mL (100 μL/well)can bind Insulin Biotin Conjugate with a linear range of 0.02-0.313 μg/mL (Routinely tested).

Protocol
Bioactivity-SPR
Human_FcRn_Heterodimer_Protein_SPR

Human Insulin R (28-944), His Tag (Cat. No. INR-H52Ha) captured on CM5 chip via anti-His antibody, can bind Human Insulin with an affinity constant of 249 nM as determined in a SPR assay (Biacore T200) (QC tested).

Protocol
  • Background
    Insulin receptor (INSR) is also known as CD antigen CD220, which can be cleaved into the following 2 chains: Insulin receptor subunit alpha and Insulin receptor subunit beta. INSR is a tetramer of 2 alpha and 2 beta chains linked by disulfide bonds. The alpha chains carry the insulin-binding regions, while the beta chains carry the kinase domain. Forms a hybrid receptor with IGF1R, the hybrid is a tetramer consisting of 1 alpha chain and 1 beta chain of INSR and 1 alpha chain and 1 beta chain of IGF1R. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Isoform Short of INSR has a higher affinity for IGFII binding. When present in a hybrid receptor with IGF1R, INSR binds IGF1.
  • References
    • (1)Pandini G., et al., 2002, J. Biol. Chem. 277:39684-39695.
    • (2)Slaaby R., et al., 2006, J. Biol. Chem. 281:25869-25874.
    • (3)Menting J.G., et al., 2013, Nature 493:241-245.
    • (4)Kadowaki T., et al., 1988, Science 240:787-790.
  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

ACROBiosystems 公司是一个具有全球范围影响力的生物技术领导品牌,其运营包扩了位于北美、欧洲和亚洲的数家公司, 主要为生命科学研究、生物制药与疫病诊断等行业提供产品、技术服务和临床应用等解决方案,同时致力于在蛋白组学、药物发现和细胞治疗等领域推广面向工业化和临床转化的技术和产品。ACROBiosystems 的业务遍及全球60多个国家和地区,并通过在中国、英国等世界范围的不同时区设立分支机构以服务于当地客户与经销商。 ACROBiosystems 中国公司成立于2010年, 并分别在北京、上海、武汉等多个城市分别建立了技术中心、销售渠道,通过执行ACROBiosystems全球用户市场策略,致力于将最优质的产品与服务提供给中国客户。 ACROBiosystems主要产品:ActiveMax®细胞因子、生物标志物蛋白、生物素标记蛋白、重元素标记蛋白、CD抗原、抗体、病毒研究相关蛋白、细胞培养产品、亲合分离介质、重组蛋白、基因等